参 考 文 献

1. CDC. Public Health Service inter-agency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis C. MMWR 1991; 40(No. RR-4): 1–17.

2. CDC. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR 1998; 47(No. RR-19): 1–33.

3. CDC. Revised guidelines for HIV counseling, testing, and referral. MMWR 2001; 50(No. RR-19): 1–53.

4. Kleinman S, Alter H, Busch M, et al. Increased detection of hepatitis C virus (HCV)-infected blood donors by a multiple-antigen HCV enzyme immunoassay. Transfusion 1992; 32:805–13.

5. Conry-Cantilena C, VanRaden M, Gibble J, et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 1996; 334:1691–6.

6. Hyams KC, Riddle J, Rubertone M, et al. Prevalence and incidence of hepatitis C virus infection in the US military: a seroepidemiologic survey of 21,000 troops. Am J Epidemiol 2001; 153:764–70.

7. Alter MJ, Kruszon-Moran D, Nainan OV, et al. Prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341:556–62.

8. Montecalvo MA, Lee S, DePalma H, et al. Seroprevalence of human immunodeficiency virus-1, hepatitis B virus, and hepatitis C virus in patients having major surgery. Infect Control Hosp Epidemiol 1995; 16:627–32.

9. Goetz AM, Ndimbie OK, Wagener MM, Muder RR. Prevalence of hepatitis C infection in health care workers affiliated with a liver transplant center. Transplantation 1995; 59:990–4.

10. CDC. Hepatitis C virus infection among firefighters, emergency medical technicians, and paramedics - selected locations, United States, 1991–2000. MMWR 2000; 49:660–5.

11. Gunn, RA, Murray PJ, Ackers ML, Hardison WGM, Margolis HS. Screening for chronic hepatitis B and C virus infections in an urban sexually transmitted disease clinic: rationale for integrating services. Sex Transm Dis 2001; 28:166–70.

12. Pawlotsky JM. Use and interpretation of virological tests for hepatitis C. Hepatology 2002; 36:S65–S73.

13. Nainan OV, Cromeans TL, Margolis HS. Sequence-specific, singleprimer amplification and detection of PCR products for identification of hepatitis viruses. J Virol Methods 1996; 61:127–34.

14. CDC. Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR 2001; 50(No. RR-5): 1–43.

15. National Institutes of Health. National Institutes of Health Consensus Development Conference Statement: management of hepatitis C: 2002—June 10–12, 2002. Hepatology 2002; 36:S3–S20.

16. Alter HJ, Jett BW, Polito AJ, et al. Analysis of the role of hepatitis C virus in transfusion-associated hepatitis. In: Hollinger FB, Lemon SM, Margolis H.S., eds. Viral hepatitis and liver disease. Baltimore, MD: Williams and Wilkins, 1991; 396–402.

17. Busch MP, Kleinman SH, Jackson B, Stramer SL, Hewlett I, Preston S. Committee report. Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases: report of the Interorganizational Task Force on Nucleic Acid Amplification of Blood Donors. Transfusion 2000; 40:143–59.

18. Ridzon R, Gallagher K, Ciesielski C, et al. Simultaneous transmission of human immunodeficiency virus and hepatitis C virus from a needlestick injury. N Engl J Med